Dr. Kuang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 CIVIC CIRCLE BLVD
Philadelphia, PA 19104
Summary
- Dr. Andrew Kuang received his medical degree from University of Illinois College of Medicine at Chicago in Chicago, Illinois and did his residency in internal medicine at Baylor College of Medicine in Houston, Texas. He previously worked as an academic hospitalist at NewYork-Presbyterian/Columbia University Irving Medical Center in New York, New York. He now is a gastroenterology and hepatology fellow at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. His academic interests include general gastroenterology and inflammatory bowel disease. He is board certified in internal medicine.
Education & Training
University of Pennsylvania Health SystemFellowship, Gastroenterology, 2024 - 2027
Baylor College of MedicineResidency, Internal Medicine, 2020 - 2023
University of Illinois College of MedicineClass of 2020
Northwestern UniversityBachelor of Arts, Honors in Biological Sciences, Summa Cum Laude, 2011 - 2014
Certifications & Licensure
PA State Medical License 2024 - 2026
NY State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Predictors of residual neoplasia after noncurative (R1) endoscopic submucosal dissection of lesions in the gastrointestinal tract.Fares Ayoub, Mai Khalaf, Andrew G Kuang, Tara Keihanian, Salmaan Jawaid
European Journal of Gastroenterology & Hepatology. 2024-10-01 - 1 citationsPractice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center.Malek Shatila, Farzin Eshaghi, Austin R Thomas, Andrew G Kuang, Jay S Shah
Cancers. 2024-01-15 - 4 citationsEfficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, Claudia A M Fulgenzi, Martin Schönlein
Hepatology Communications. 2023-11-01
Journal Articles
- Diarrhea and colitis related to immune checkpoint inhibitor and BRAF/MEK inhibitor therapyAndrew G Kuang, Wasay Mohajir, Kavea Panneerselvam, Jennifer L McQuade, Isabella C Glitz Oliva, Muhammad Ali Khan, Hao Chi Zhang, Anusha S Thomas, Yinghong Wang, Annals of Gastroenterology, 2023
- Sclerosing mesenteritis following immune checkpoint inhibitor therapyAndrew G Kuang, Gabriel Sperling, Tom Z Liang, Yang Lu, Dongfeng Tan, Kathryn Bollin, Douglas B Johnson, Joanna-Grace M Manzano, Malek Shatila, Anusha S Thomas, John A..., Journal of Cancer Research and Clinical Oncology, 2023
- Unusual Skin Ulcerations in a Patient With HematocheziaAndrew G Kuang, Firas Bahdi, Richa Shukla, Gastroenterology, 2022
- Join now to see all
Abstracts/Posters
- Predictors of Residual Lesions in Patients with Positive Histologic Margin (R1) Following Endoscopic Submucosal Dissection: A Retrospective ReviewKhalaf M, Kuang AG, Ayoub F, Jawaid S, Othman MO, Digestive Diseases Week, 2023
- Real-World Effectiveness and Safety of Upadacitinib in Ulcerative Colitis: A Multi-Centre StudyPatel A, Johnson AM, Berinstein J, Dulaney D, Fenster M, Ayoub M, Huang K, Lieto S, Scalzo N, Loftus EV, Higgins PDR, Chowla NM, Reddy N, Yarur A, Kuang AG, Shukla R, ..., Digestive Diseases Week, 2023
- Endoscopic Intervention After Abdominal Trauma: A Single Center PerspectiveAnkur Patel, Andrew G Kuang, RJ Sealock, Digestive Diseases Week, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
